Leslie Raffini

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

Stephen R. Russell, Jean Bennett, Jennifer Wellman et al. · The Lancet · 2017 · 1.8K citations · Full text

Ocular Disease, Retina, Ophthalmology +6

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

Albert M. Maguire, Katherine A. High, Alberto Auricchio et al. · The Lancet · 2009 · 849 citations

Gene Therapies, Genetic Disorder, Genetics +7

Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007

Leslie Raffini, Yuan‐Shung Huang, Char Witmer et al. · PEDIATRICS · 2009 · 805 citations

American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism

Paul Monagle, Carlos A. Cuello‐García, Caitlin Augustine et al. · Blood Advances · 2018 · 425 citations · Full text

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 294 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9